Pneumococcal 13-valent conjugate vaccine (Kunli Biopharmaceuticals)

13价肺炎球菌多糖结合疫苗（坤力生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePneumococcal 13-valent conjugate vaccine (Kunli Biopharmaceuticals)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSepsisPneumonia, PneumococcalPneumococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Kunli Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kunli Biopharmaceutical Co LtdJiangsu Kunli Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSepsisPneumonia, PneumococcalPneumococcal Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A